Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Fatty Acids, Omega-3 and Aldesleukin

Research Papers that Mention the Interaction

The n-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can suppress T-cell proliferation and the production of interleukin-1, interleukin-2 , and tumor necrosis factor by these cells both in vitro and in vivo.
Prostaglandins, leukotrienes, and essential fatty acids  •  1994  |  View Paper
N-3 fatty acids can inhibit the synthesis and release of pro-inflammatory cytokines such as tumor necrosis factoralpha (TNFalpha) and interleukin-1 (IL-1) and IL-2 that are released during the early course of ischemic heart disease.
Prostaglandins, leukotrienes, and essential fatty acids  •  2000  |  View Paper
CONCLUSION Short-term omega-3 fatty acid supplementation (3 g/day for eight weeks) can decrease the serum levels of TNF-α and IL-2 in diabetic patients, with no change in CRP levels.
Singapore medical journal  •  2013  |  View Paper
Consequently, N-3 fatty acids can inhibit the synthesis of proinflammatory cytokines, eg, tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and IL-2 ; these in turn may destabilize atherosclerotic lesions.
Circulation  •  2003  |  View Paper
…,omega 3 fatty acids inhabited the expressions of inflammatory cells (CD4, CD8 and CD11b) and suppressed the level of NF-κB. The echocardiographic …, levels of LVDs, LVDd, LVPW percentage of LVFS, EF, expression levels of inflammatory cytokines (TNF, IL-1β, IFN-ɤ, IL-2 , and IL-6) … fatty acids.
Zeitschrift fur Naturforschung. C, Journal of biosciences  •  2021  |  View Paper